EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 46 / No 2 (June 2014) J Extra Corpor Technol, 46 2 (2014) 130-141 References
Free Access
Review
Issue
J Extra Corpor Technol
Volume 46, Number 2, June 2014
Page(s) 130 - 141
DOI https://doi.org/10.1051/ject/201446130
Published online 15 June 2014
  1. Filsoufi F, Rahmanian P, Castillo J, et al. Predictors and early and late outcomes of respiratory failure in contemporary cardiac surgery. Chest. 2008;133:713–721. [CrossRef] [Google Scholar]
  2. Boyle E, Pohlman T, Johnson M, et al. Endothelial cell injury in cardiovascular surgery: The systemic inflammatory response. Ann Thorac Surg. 1997;63:277–284. [CrossRef] [Google Scholar]
  3. The ARDS Definition Task Force. Acute respiratory distress syndrome, the Berlin definition. JAMA. 2012;307:2526–2533. [PubMed] [Google Scholar]
  4. Asimakopoulos G, Taylor K, Smith P, et al. Prevalence of acute respiratory distress syndrome after cardiac surgery. J Thorac Cardiovasc Surg. 1999;68:1107–1115. [Google Scholar]
  5. Milot J, Perron J, Lacasse Y, et al. Incidence and predictors of ARDS in cardiac surgery. Chest. 2001;119:884–888. [CrossRef] [PubMed] [Google Scholar]
  6. Kogan A, Preisman S, Levin S, et al. Adult respiratory distress syndrome following cardiac surgery. J Card Surg. 2014;29:41–46. [CrossRef] [Google Scholar]
  7. Laffey J, Boylan J, Cheng D. The systemic inflammatory response to cardiac surgery. Implications for the anesthesiologist. Anesthesiology. 2002;97:215–252. [CrossRef] [PubMed] [Google Scholar]
  8. Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mol Med. 2010;17:293–307. [Google Scholar]
  9. Hengst W, Gielis J, Lin J, et al. Lung ischaemia–reperfusion injury: A molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol. 2010;299:H1283–H1299. [CrossRef] [PubMed] [Google Scholar]
  10. Landis C, Murkin R, Stump D, et al. Consensus statement: Minimal criteria for the reporting of the systemic inflammatory response to cardiopulmonary bypass. Heart Surg Forum. 2010;13:E108A–E115A. [Google Scholar]
  11. Butler J, Rocker G, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55:552–559. [CrossRef] [Google Scholar]
  12. Wendel H, Ziemer G. Coating—Techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg. 1999;16:342–350. [CrossRef] [Google Scholar]
  13. Sohn N, Marcoux J, Mycyk T, et al. The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress. Perfusion. 2009;24:231–237. [CrossRef] [PubMed] [Google Scholar]
  14. Ranucci M, Balduini A, Ditta A, et al. A systematic review of biocompatible cardiopulmonary bypass circuits and clinical outcome. Ann Thorac Surg. 2009;87:1311–1319. [CrossRef] [Google Scholar]
  15. Hall R. Identification of inflammatory mediators and their modulation by strategies for the management of the systemic inflammatory response during cardiac surgery. J Cardiothorac Vasc Anesth. 2013;27:983–1033. [CrossRef] [Google Scholar]
  16. Anastasiadis K, Antonitsis P, Haidich A, et al. Use of minimal extracorporeal circulation improves outcome after heart surgery; A systemic review and meta analysis of randomized controlled trials. Int J Cardiol. 2013;164:158–169. [CrossRef] [Google Scholar]
  17. Raja S, Dreyfus G. Current status of off-pump coronary artery surgery. Asian Cardiovasc Thorac Ann. 2008;16:164–178. [CrossRef] [PubMed] [Google Scholar]
  18. Kochamba G, Yun L, Pfeffer A, et al. Pulmonary abnormalities after coronary arterial bypass grafting operation: Cardiopulmonary bypass versus mechanical stabilization. Ann Thorac Surg. 2000;69:1466–1470. [CrossRef] [Google Scholar]
  19. Vedin J, Jensen U, Ericsson A, et al. Pulmonary hemodynamics and gas exchange in off pump coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2005;4:493–497. [CrossRef] [PubMed] [Google Scholar]
  20. Cimen S, Ozkul V, Ketenci B, et al. Daily comparison of respiratory functions between on-pump and off-pump patients undergoing CABG. Eur J Cardiothorac Surg. 2003;23:589–594. [CrossRef] [Google Scholar]
  21. Meharwal Z, Mishra Y, Kohli V, et al. Off-pump multivessel coronary artery surgery in high-risk patients. Ann Thorac Surg. 2002;74:S1353–S1357. [CrossRef] [Google Scholar]
  22. Møller C, Perko M, Lund J, et al. No major differences in 30-day outcomes in high-risk patients randomized to off-pump versus on-pump coronary bypass surgery. The Best Bypass Surgery Trial. Circulation. 2010;121:498–504. [CrossRef] [PubMed] [Google Scholar]
  23. LaPar D, Bhamidipati C, Reece T, et al. Is off-pump coronary artery bypass grafting superior to conventional bypass in octogenarians? J Thorac Cardiovasc Surg. 2011;141:81–90. [CrossRef] [Google Scholar]
  24. Sarin E, Kayatta M, Kilgo P, et al. Short- and long-term outcomes in octogenarian patients undergoing off-pump coronary artery bypass grafting compared with on-pump coronary artery bypass grafting. Innovations, Technology and Techniques in Cardiothoracic and Vascular Surgery. 2011;6:110–115. [CrossRef] [PubMed] [Google Scholar]
  25. Pawlaczyk R, Swietlik D, Lango R, et al. Off-pump coronary surgery may reduce stroke, respiratory failure and mortality in octogenarians. Ann Thorac Surg. 2012;94:29–37. [CrossRef] [Google Scholar]
  26. Kerendi F, Halkos M, Puskas J, et al. Impact of off-pump coronary artery bypass graft surgery on postoperative pulmonary complications in patients with chronic lung disease. Ann Thorac Surg. 2011;91:8–15. [CrossRef] [Google Scholar]
  27. Magilligan D, Oyama C. Ultrafiltration during cardiopulmonary bypass: Laboratory evaluation and initial clinical experience. Ann Thorac Surg. 1984;37:33–39. [CrossRef] [Google Scholar]
  28. Boodhwani M, Williams K, Babaev A, et al. Ultrafiltration reduces blood transfusions following cardiac surgery: A meta-analysis. Eur J Cardiothorac Surg. 2006;30:892–897. [CrossRef] [Google Scholar]
  29. Journais D, Israel-Biet D, Pouard P, et al. High-volume, zero-balanced haemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology. 1996;85:965–976. [CrossRef] [PubMed] [Google Scholar]
  30. Berdat P, Eichenberger E, Ebell J, et al. Elimination of proinflammatory cytokines in pediatric cardiac surgery: Analysis of ultrafiltration method and filter type. J Thorac Cardiovasc Surg. 2004;127:1688–1696. [CrossRef] [Google Scholar]
  31. Zhu X, Wang G, Long C. The effects of zero-balance ultrafiltration on postoperative recovery after cardiopulmonary bypass: A metaanalysis of randomized controlled trials. Perfusion. 2012;27:386–392. [CrossRef] [PubMed] [Google Scholar]
  32. Mahmoud A, Burhani M, Hannef A, et al. Effect of modified ultrafiltration on pulmonary function after cardiopulmonary bypass. Chest. 2005;128:3447–3453. [CrossRef] [PubMed] [Google Scholar]
  33. Keenan H, Thiagarajan R, Stephens K, et al. Pulmonary function after modified venovenous filtration in infants: A prospective, randomized trial. J Thorac Cardiovasc Surg. 2000;119:501–505. [CrossRef] [Google Scholar]
  34. Luciani G, Menon T, Vecchi B, et al. Modified ultrafiltration reduces morbidity after adult cardiac operations: A prospective, randomized clinical trial. Circulation. 2001;104(suppl I):I-253–I-259. [CrossRef] [Google Scholar]
  35. Belway D, Rubens F, Wozny D, et al. Are we doing everything we can to conserve blood during bypass? A national survey. Perfusion. 2005;20:237–241. [CrossRef] [PubMed] [Google Scholar]
  36. Wang G, Bainbridge D, Martin J, et al. The efficacy of an intraoperative cell saver during cardiac surgery: A meta-analysis of randomized trials. Anesth Analg. 2009;109:320–330. [CrossRef] [PubMed] [Google Scholar]
  37. Koch C, Li L, Figueroa P, et al. Transfusion and pulmonary morbidity after cardiac surgery. Ann Thorac Surg. 2009;88:1410–1418. [CrossRef] [Google Scholar]
  38. Westerberg A, Bengtsson A, Jeppsson A. Coronary surgery without cardiac suction and autotransfusion reduces the postoperative systemic inflammatory response. Ann Thorac Surg. 2004;78:54–59. [CrossRef] [Google Scholar]
  39. Solis R, Noon G, Beall A, et al. Particulate microembolism during cardiac operation. Ann Thorac Surg. 1974;17:332–344. [CrossRef] [Google Scholar]
  40. Amand T, Pincemail J, Blaffart F, et al. Levels of inflammatory markers in the blood processed by autotransfusion devices during cardiac surgery associated with cardiopulmonary bypass circuit. Perfusion. 2002;17:117–123. [CrossRef] [PubMed] [Google Scholar]
  41. Gäbel J, Westerberg M, Bengtsson A, et al. Cell salvage of cardiotomy suction blood improves the balance between pro- and anti-inflammatory cytokines after cardiac surgery. Eur J Cardiothorac Surg. 2013;44:506–511. [CrossRef] [PubMed] [Google Scholar]
  42. Damgaard S, Nielson C, Andersen L, et al. Cell saver for on-pump coronary operations reduces systemic inflammatory markers: A randomized trial. Ann Thorac Surg. 2010;89:1511–1517. [CrossRef] [Google Scholar]
  43. Serrick C, Scholz M, Melo A, et al. Quality of red blood cells using autotransfusion devices: A comparative analysis. J ECT. 2003;35:28–34. [Google Scholar]
  44. Boodhwani M, Nathan H, Mesana T, et al. Effects of shed mediastinal blood on cardiovascular and pulmonary function: A randomized, double-blind study. Ann Thorac Surg. 2008;86:1167–1174. [CrossRef] [Google Scholar]
  45. Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mol Med. 2011;17:293–307. [CrossRef] [PubMed] [Google Scholar]
  46. Warren O, Alexiou C, Massey R, et al. The effects of various leukocyte filtration strategies in cardiac surgery. Eur J Cardiothorac Surg. 2007;31:665–676. [CrossRef] [Google Scholar]
  47. Warren O, Tunnicliffe C, Massey R, et al. Systemic leukofiltration does not attenuate pulmonary injury after cardiopulmonary bypass. ASAIO J. 2008;54:78–88. [CrossRef] [PubMed] [Google Scholar]
  48. Bechtel J, Muhlenbein S, Eichler W, et al. Leukocyte depletion during cardiopulmonary bypass in routine adult cardiac surgery. Interact Cardiovasc Thorac Surg. 2011;12:207–212. [CrossRef] [PubMed] [Google Scholar]
  49. Ferraris V, Brown J, Despotis G, et al. The 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91:944–982. [CrossRef] [Google Scholar]
  50. Halter J, Steinberg J, Gatto L, et al. Effect of positive end-expiratory pressure and tidal volume on lung injury induced by alveolar instability. Crit Care. 2007;11:R20. [CrossRef] [PubMed] [Google Scholar]
  51. De Oliveira R, Hetzel M, Silva M, et al. Mechanical ventilation with high tidal volume induces inflammation in patients without lung disease. Crit Care. 2010;14:R39. [CrossRef] [PubMed] [Google Scholar]
  52. Determann R, Royakkers A, Wolthuis E, et al. Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: A preventative randomized controlled trial. Crit Care. 2010;14:R1. [CrossRef] [PubMed] [Google Scholar]
  53. The Acute Respiratory Distress Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–1308. [CrossRef] [PubMed] [Google Scholar]
  54. Zupancich E, Paparella D, Turani F, et al. Mechanical ventilation affects inflammatory mediators in patients undergoing cardiopulmonary bypass for cardiac surgery: A randomized clinical trial. J Thorac Cardiovasc Surg. 2005;130:378–383. [CrossRef] [Google Scholar]
  55. Wrigge H, Uhlig U, Baumgarten G, et al. Mechanical ventilation strategies and inflammatory responses to cardiac surgery: A prospective randomized clinical trial. Intensive Care Med. 2005;31:1379–1387. [CrossRef] [PubMed] [Google Scholar]
  56. Chaney M, Nikolov M, Blakeman B, et al. Protective ventilation attenuates postoperative pulmonary dysfunction in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2000;14:5154–5518. [Google Scholar]
  57. Schreiber J, Lancé M, De Korte M, et al. The effects of different lung-protective strategies in patients during cardiopulmonary bypass: A meta-analysis and semi quantitative review of randomized trials. J Cardiothorac Vasc Anesth. 2012;26:448–454. [CrossRef] [Google Scholar]
  58. Okuda M, Furuhashi K, Muneyuki M. Decrease of ischaemia–reperfusion related lung oedema by continuous ventilation and allopurinol in rat perfusion lung model. Scand J Clin Lab Invest. 1993;53:625–631. [CrossRef] [PubMed] [Google Scholar]
  59. Imura H, Caputo M, Lim K, et al. Pulmonary injury after cardiopulmonary bypass: Beneficial effects of low frequency mechanical ventilation. J Thorac Cardiovasc Surg. 2009;137:1530–1537. [CrossRef] [Google Scholar]
  60. John L, Ervine I. A study assessing the potential benefit of continued ventilation during cardiopulmonary bypass. Interact Cardiovasc Thorac Surg. 2008;7:14–17. [CrossRef] [PubMed] [Google Scholar]
  61. Gagnon J, Laporta D, Béïque F, et al. Clinical relevance of ventilation during cardiopulmonary bypass in the prevention of postoperative lung dysfunction. Perfusion. 2010;25:205–210. [CrossRef] [PubMed] [Google Scholar]
  62. Schlensak C, Doenst T, Preusser S, et al. Bronchial artery perfusion during cardiopulmonary bypass does not prevent ischaemia of the lung in piglets: Assessment of bronchial artery blood flow with fluorescent microspheres. Eur J Cardiothorac Surg. 2001;19:326–331. [CrossRef] [PubMed] [Google Scholar]
  63. Schlensak C, Doenst T, Preusser S, et al. Cardiopulmonary bypass reduction of bronchial blood flow: A potential mechanism for lung injury in a neonatal pig model. J Thorac Cardiovasc Surg. 2002;123:1199–1205. [CrossRef] [Google Scholar]
  64. Serraf A, Sellak H, Hervé P, et al. Vascular endothelium viability and function after total cardiopulmonary bypass in neonatal pigs. Am J Respir Crit Care Med. 1999;159:544–551. [Google Scholar]
  65. Massoudy P, Zahler S, Becker B, et al. Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass. Chest. 2001;119:31–36. [CrossRef] [PubMed] [Google Scholar]
  66. Siepe M, Goebel U, Mecklenburg A, et al. Pulsatile pulmonary perfusion during cardiopulmonary bypass reduces the pulmonary inflammatory response. Ann Thorac Surg. 2008;86:115–122. [CrossRef] [Google Scholar]
  67. Suzuki T, Fukuda T, Ito T, et al. Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants. Ann Thorac Surg. 2000;69:602–606. [CrossRef] [Google Scholar]
  68. Santini F, Onorati F, Telesca M, et al. Pulsatile pulmonary perfusion with oxygenated blood ameliorates pulmonary haemodynamic and respiratory indices in low-risk coronary artery bypass patients. Eur J Cardiothorac Surg. 2011;40:794–803. [Google Scholar]
  69. Liu Y, Wang Q, Zhu X, et al. Pulmonary artery perfusion with protective solution reduces lung injury after cardiopulmonary bypass. Ann Thorac Surg. 2000;69:1402–1407. [CrossRef] [Google Scholar]
  70. Sievers H, Freund-Kaas C, Eleftheriadis S, et al. Lung protection during total cardiopulmonary bypass by isolated lung perfusion: Preliminary results of a novel perfusion strategy. Ann Thorac Surg. 2002;74:1167–1172. [CrossRef] [Google Scholar]
  71. Drew C, Anderson I. Profound hypothermia in cardiac surgery. Report of three cases. Lancet. 1959;1:748–750. [CrossRef] [Google Scholar]
  72. Richter J, Meisner H, Tassani P, et al. Drew-Anderson technique attenuates systemic inflammatory response syndrome and improves respiratory function after coronary artery bypass grafting. Ann Thorac Surg. 2000;69:77–83. [CrossRef] [Google Scholar]
  73. Heinze H, Rosemann C, Weber C, et al. A single dose of pentoxifylline reduces high dependency unit time in cardiac surgery—A prospective randomized and controlled study. Eur J Cardiothorac Surg. 2007;32:83–89. [CrossRef] [Google Scholar]
  74. Welters I, Feurer M, Preiss V, et al. Continuous S-(+)-ketamine administration during elective coronary artery bypass graft surgery attenuates pro-inflammatory cytokine response during and after cardiopulmonary bypass. Br J Anaesth. 2011;106:172–179. [CrossRef] [Google Scholar]
  75. Luo W, Ling X, Huang R. Effects of aminophylline on cytokines and pulmonary function in patients undergoing valve replacement. Eur J Cardiothorac Surg. 2004;25:766–771. [CrossRef] [Google Scholar]
  76. Qu X, Li Q, Wang X, et al. N-acetylcysteine attenuates cardiopulmonary bypass-induced lung injury in dogs. J Cardiothorac Surg. 2013;8:107–113. [CrossRef] [Google Scholar]
  77. Castillo R, Rodrigo R, Perez F, et al. Antioxidant therapy reduces oxidative and inflammatory tissue damage in patients subjected to cardiac surgery with extracorporeal circulation. Basic Clin Pharmacol Toxicol. 2010;108:256–262. [Google Scholar]
  78. Whitlock R, Chan S, Devereaux P, et al. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: A meta-analysis of randomized trials. Eur Heart J. 2008;29:2592–2600. [CrossRef] [PubMed] [Google Scholar]
  79. Cappabianca G, Rotunno C, Schinosa L, et al. Protective effects of steroids in cardiac surgery: A meta-analysis of randomized double blind trials. J Cardiothorac Vasc Anesth. 2011;25:156–165. [CrossRef] [Google Scholar]
  80. Dieleman J, Nierich A, Rosseel P, et al. Intraoperative high-dose dexamethasone for cardiac surgery. A randomized controlled trial. JAMA. 2012;308:1761–1767. [CrossRef] [PubMed] [Google Scholar]
  81. Joyce C, Williams A. Kinetics of absorption atelectasis during anesthesia: A mathematical model. J Appl Physiol. 1999;86:1116–1125. [CrossRef] [PubMed] [Google Scholar]
  82. Edmark L, Kostova-Aherdan K, Enlund M, et al. Optimal oxygen concentration during induction of general anesthesia. Anesthesiology. 2003;98:28–33. [CrossRef] [PubMed] [Google Scholar]
  83. Magnusson L, Zemgulis V, Wicky S, et al. Atelectasis is a major cause of hypoxaemia and shunt after cardiopulmonary bypass. Anesthesiology. 1997;87:1153–1163. [CrossRef] [PubMed] [Google Scholar]
  84. Carvalho R, Schettino G, Maranhao B, et al. Hyperoxia and lung disease. Curr Opin Pulm Med. 1998;4:300–304. [CrossRef] [PubMed] [Google Scholar]
  85. Sue R, Belperio J, Burdick M, et al. CXCR2 is critical to hyperoxia-induced lung injury. J Immunol. 2004;172:3860–3868. [CrossRef] [PubMed] [Google Scholar]
  86. Sinclair S, Altemeier W, Matute-Bello G, et al. Augmented lung injury due to the interaction between hyperoxia and mechanical ventilation. Crit Care Med. 2004;32:2496–2501. [CrossRef] [PubMed] [Google Scholar]
  87. Brueckl C, Kaestle S, Kerem A, et al. Hyperoxia-induced reactive oxygen species formation in pulmonary capillary endothelial cells in situ. Am J Respir Cell Mol Biol. 2006;34:453–463. [Google Scholar]
  88. Ihnken K, Winkler A, Schlensak C, et al. Normoxic cardiopulmonary bypass reduces oxidative myocardial damage and nitric oxide. Thorac Cardiovasc Surg. 1998;116:327–334. [CrossRef] [Google Scholar]
  89. Reber A, Budmiger B, Wenk M, et al. Inspired oxygen concentration after cardiopulmonary bypass: Effects on pulmonary function with regard to endothelin-1 concentrations and venous admixture. Br J Anaesth. 2000;84:565–570. [CrossRef] [Google Scholar]
  90. Pizov R, Weiss Y, Oppenheim-Eden A, et al. High oxygen concentration exacerbates cardiopulmonary bypass-induced lung injury. J Cardiothorac Vasc Anesth. 2000;14:519–523. [CrossRef] [Google Scholar]
  91. Rehm M, Haller M, Orth V, et al. Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solution in patients before radical hysterectomy. Anesthesiology. 2001;95:849–856. [CrossRef] [PubMed] [Google Scholar]
  92. Hoeft A, Korb H, Mehlhorn U, et al. Priming of cardiopulmonary bypass with human albumin or Ringer lactate: Effect on colloid osmotic pressure and extravascular lung water. Br J Anaesth. 1991;66:73–80. [CrossRef] [Google Scholar]
  93. Eising G, Pfauder M, Niemeyer M, et al. Retrograde autologous priming: Is it useful in elective on-pump coronary artery bypass surgery? Ann Thorac Surg. 2003;75:23–27. [CrossRef] [Google Scholar]
  94. Osman D, Ridel C, Ray P, et al. Cardiac filling pressures are not appropriate to predict haemodynamic response to volume challenge. Crit Care Med. 2007;35:64–68. [CrossRef] [PubMed] [Google Scholar]
  95. Marik P, Baram M, Vahid B. Does the central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest. 2008;134:172–178. [CrossRef] [PubMed] [Google Scholar]
  96. Marik P, Cavallazi R, Vasu T, et al. Stroke volume variation and fluid responsiveness. A systematic review of the literature. Crit Care Med. 2009;37:2642–2647. [CrossRef] [PubMed] [Google Scholar]
  97. Preisman S, Kogan S, Berkenstadt H, et al. Predicting fluid responsiveness in patients undergoing cardiac surgery: Functional haemodynamic parameters including the respiratory systolic variation test and static preload indicators. Br J Anaesth. 2005;95:746–755. [CrossRef] [Google Scholar]
  98. Belloni L, Pisano A, Natale A, et al. Assessment of fluid-responsiveness parameters for off-pump coronary artery bypass surgery: A comparison among LiDCO, transoesophageal echocardiography, and pulmonary artery catheter. J Cardiothorac Vasc Anesth. 2008;22:243–248. [CrossRef] [Google Scholar]
  99. Vieillard-Baron A, Chergui K, Peyrouset O, et al. Superior vena caval collapsibility as a gauge of volume status in ventilated septic patients. Intensive Care Med. 2004;30:1734–1739. [Google Scholar]
  100. Koch C, Li L, Figueroa P, et al. Transfusion and pulmonary morbidity after cardiac surgery. Ann Thorac Surg. 2009;88:1410–1418. [CrossRef] [Google Scholar]
  101. Hebert P, Yetisir E, Martin C, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med. 2001;29:227–234. [CrossRef] [PubMed] [Google Scholar]
  102. Hajjar L, Vincent J, Galas F, et al. Transfusion requirements after cardiac surgery. JAMA. 2010;304:1559–1567. [CrossRef] [PubMed] [Google Scholar]
  103. Møller C, Perko M, Lund J, et al. No major differences in 30-day outcomes in high-risk patients randomized to off-pump versus on-pump coronary bypass surgery. The Best Bypass Surgery Trial. Circulation. 2010;121:498–504. [CrossRef] [PubMed] [Google Scholar]
  104. Hattler B, Messenger J, Shroyer L, et al. Off-pump coronary artery bypass surgery is associated with worse arterial and saphenous vein graft patency and less effective revascularization. Results from the Veterans Affairs Randomized On/Off Bypass (ROOBY) Study Group. Circulation. 2012;125:2827–2835. [CrossRef] [PubMed] [Google Scholar]
  105. Kor D, Warner D, Alsara A, et al. Derivation and diagnostic accuracy of the surgical lung injury prediction model. Anesthesiology. 2011;115:117–128. [CrossRef] [PubMed] [Google Scholar]
  106. Adabag A, Wassif H, Rice K, et al. Preoperative pulmonary function and mortality after cardiac surgery. Am Heart J. 2010;159:691–697. [CrossRef] [Google Scholar]
  107. Dodd-o J, Hristopoulos M, Welsh-Servinsky L, et al. Strain specific differences in sensitivity to ischaemia–reperfusion lung injury in mice. J Appl Physiol. 2006;100:1590–1595. [CrossRef] [PubMed] [Google Scholar]
  108. Chen S, Xu L, Tang J. Association of interleukin 18 gene polymorphism with susceptibility to the development of acute lung injury after cardiopulmonary bypass surgery. Tissue Antigens. 2010;76:245–249. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.